Skip to main content
. 2017 Feb 8;8(14):22783–22799. doi: 10.18632/oncotarget.15199

Figure 2.

Figure 2

Concentrations of four identified serum lncRNAs in GBM patients showing response (n = 70) and non-response (n = 70) to TMZ therapy using RT-qPCR assay in validation set (AD). **P < 0.01.